BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1888162)

  • 1. Antiinvasive activity of hexadecylphosphocholine in vitro.
    Schallier DC; Bruyneel EA; Storme GA; Hilgard P; Mareel MM
    Anticancer Res; 1991; 11(3):1285-92. PubMed ID: 1888162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.
    Storme GA; Berdel WE; van Blitterswijk WJ; Bruyneel EA; De Bruyne GK; Mareel MM
    Cancer Res; 1985 Jan; 45(1):351-7. PubMed ID: 4038380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the host tissue in the anti-invasive activity of the alkyllysophospholipid, ET-18-OCH3, in vitro.
    Schallier DC; Bruyneel EA; Storme GA; Mareel MM
    Clin Exp Metastasis; 1991; 9(6):579-91. PubMed ID: 1752086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexadecylphosphocholine inhibits invasion of mouse T-cell lymphoma cells in two different invasion assays.
    Schaider H; Seidl H; Berger MR; Hofmann-Wellenhof R; Tritthart HA; Smolle J
    Anticancer Res; 1998; 18(2A):995-8. PubMed ID: 9615753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues.
    Berkovic D; Haase D; Hiddemann W; Fleer EA
    J Exp Ther Oncol; 1996 Nov; 1(6):368-75. PubMed ID: 9414427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
    Berkovic D; Berkovic K; Fleer EA; Eibl H; Unger C
    Eur J Cancer; 1994; 30A(4):509-15. PubMed ID: 8018410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
    Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
    Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids.
    Lu X; Arthur G
    Cancer Res; 1992 May; 52(10):2813-7. PubMed ID: 1581895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell kill and cytostasis by ET-18-OCH3 and heat.
    Fujiwara K; Modest EJ; Wallen CA
    Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
    Civoli F; Daniel LW
    Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro.
    Danhauser-Riedl S; Himmelmann A; Steinhauser G; Busch R; Vogler WR; Rastetter J; Berdel WE
    J Lipid Mediat; 1990; 2(5):271-80. PubMed ID: 2133272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
    Samadder P; Arthur G
    Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
    Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines.
    Lu X; Arthur G
    Cancer Res; 1992 May; 52(10):2806-12. PubMed ID: 1581894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interference effects of hexadecylphosphocholine on proliferation and membrane phospholipid metabolism in human myeloid leukemia cell lines.
    Wang YZ; Chang YB; Xing C; Fu D
    Int J Tissue React; 1998; 20(3):101-7. PubMed ID: 9894183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
    Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
    Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
    Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferation effects of hexadecylphosphocholine on solid tumour and leukaemia selectively in vitro.
    Wang YZ; Liu XY; Wu LJ; Zhang YB; Hou L; Xu QS
    Drugs Exp Clin Res; 1997; 23(3-4):97-102. PubMed ID: 9403269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.
    Kosano H; Yasutomo Y; Kugai N; Nagata N; Inagaki H; Tanaka S; Takatani O
    Cancer Res; 1990 Jun; 50(11):3172-5. PubMed ID: 2334912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiinvasive activity of estramustine on malignant MO4 mouse cells and on DU-145 human prostate carcinoma cells in vitro.
    Mareel MM; Storme GA; Dragonetti CH; De Bruyne GK; Hartley-Asp B; Segers JL; Rabaey ML
    Cancer Res; 1988 Apr; 48(7):1842-9. PubMed ID: 3349462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.